Molinos Rio de la Plata S.A. (BCBA:MOLI5)

Ligand Pharmaceuticals Balance Sheet

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	33,627	30,124	101,903	12,833	3,385	4,741
Cash & Short-Term Investments	33,627	30,124	101,903	12,833	3,385	4,741
Cash Growth	-37.90%	-70.44%	694.09%	279.10%	-28.60%	373.93%
Accounts Receivable	131,121	85,166	110,164	40,132	10,712	5,854
Other Receivables	10,071	15,135	11,050	3,555	1,590	605
Receivables	142,026	101,409	122,839	44,174	12,474	6,561
Inventory	172,753	185,625	227,617	118,293	33,435	15,144
Prepaid Expenses	1,265	422	162	62.3	192.3	196.27
Other Current Assets	8,874	8,783	10,813	9,742	2,356	1,265
Total Current Assets	358,545	326,363	463,334	185,104	51,842	27,908
Property, Plant & Equipment	260,113	230,038	218,222	100,651	33,970	18,928
Long-Term Investments	34,738	32,122	38,763	15,027	3,473	1,886
Other Intangible Assets	42,965	36,908	35,956	17,493	5,868	3,125
Other Long-Term Assets	24,344	20,840	17,297	8,131	3,405	1,971
Total Assets	722,108	647,182	774,509	327,244	98,752	53,928
Accounts Payable	127,309	122,920	155,661	66,038	17,012	8,144
Accrued Expenses	23,129	26,013	26,451	13,784	3,316	2,477
Short-Term Debt	17,757	8,123	8,746	18,294	10,007	6,810
Current Portion of Long-Term Debt	118,984	67,340	48,449	14,806	7,063	3,015
Current Portion of Leases	-	281	1,019	346.87	136.66	94.23
Current Income Taxes Payable	-	-	32,089	4,348	-	0.55
Other Current Liabilities	6,836	8,518	7,103	6,438	781.47	428.44
Total Current Liabilities	294,015	233,195	279,518	124,054	38,316	20,969
Long-Term Debt	42,175	51,600	70,949	27,584	6,645	8,136
Long-Term Leases	-	-	479	733.5	296.01	274.65
Long-Term Deferred Tax Liabilities	51,488	55,154	58,552	32,023	13,438	4,829
Other Long-Term Liabilities	5,603	4,946	5,432	1,297	2,090	1,231
Total Liabilities	393,281	344,895	414,930	185,692	60,786	35,440
Common Stock	201	201	201	201.42	201.42	201.42
Additional Paid-In Capital	40,440	35,136	35,136	16,135	5,181	2,660
Retained Earnings	101,701	105,291	154,404	48,931	7,259	2,635
Comprehensive Income & Other	186,485	161,659	169,838	76,285	25,324	12,991
Shareholders' Equity	328,827	302,287	359,579	141,552	37,966	18,488
Total Liabilities & Equity	722,108	647,182	774,509	327,244	98,752	53,928
Total Debt	178,916	127,344	129,642	61,765	24,147	18,330
Net Cash (Debt)	-145,289	-97,220	-27,739	-48,932	-20,762	-13,589
Net Cash Per Share	-722.83	-483.68	-138.00	-242.94	-103.08	-67.47
Filing Date Shares Outstanding	201.42	201.42	201.42	201.42	201.42	201.42
Total Common Shares Outstanding	201.42	201.42	201.42	201.42	201.42	201.42
Working Capital	64,530	93,168	183,816	61,050	13,526	6,938
Book Value Per Share	1632.58	1500.82	1785.26	702.79	188.50	91.79
Tangible Book Value	285,862	265,379	323,623	124,059	32,098	15,362
Tangible Book Value Per Share	1419.27	1317.57	1606.75	615.94	159.36	76.27
Land	26,968	23,397	22,388	10,281	3,305	1,699
Buildings	159,249	137,522	135,429	62,185	19,940	10,090
Machinery	699,606	595,713	583,304	262,680	82,957	42,208
Construction In Progress	14,521	22,204	13,791	3,102	692.44	1,064

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.